Introduction:
This article discusses the current state of productivity in the biotechnology industry and explores whether downstream productivity will catch up with upstream by 2024. It examines the key factors influencing downstream productivity and the potential implications for the industry.
- Currently, upstream processing in the biotechnology industry is more productive than downstream processing.
- Downstream processing involves several steps, including centrifugation, filtration, and chromatographic technologies, to remove contaminants from bioreactor harvest.
- The lower productivity of downstream processing is due to the complexity and variability of the purification steps.
- Advancements in technology and process optimization are expected to improve downstream productivity in the coming years.
- However, challenges such as the need for specialized expertise and high costs may hinder the progress of downstream productivity.
Conclusion:
While downstream productivity in the biotechnology industry still lags behind upstream processing, efforts are being made to bridge this gap. Advancements in technology and process optimization show promise for improving downstream productivity in the coming years. However, challenges such as expertise and cost may need to be addressed for downstream productivity to catch up with upstream. The implications of improving downstream productivity include increased efficiency, reduced costs, and enhanced competitiveness for biotechnology companies. Overall, the industry is optimistic about the potential for downstream productivity to catch up with upstream by 2024.
